Product Overview Dayline 250mg Iv Inj by High Q is a powerful antibiotic injection that contains the active ingredient Ceftriaxone. It is used to treat a wide range of bacterial infections in the body, including respiratory tract infections, skin infections, urinary tract infections, and more. This injection is administered intravenously by a healthcare professional. Key Benefits - Effective treatment for a variety of bacterial infections - Fast-acting formula for quick relief - Convenient intravenous administration for efficient absorption - High potency of Ceftriaxone for maximum effectiveness - Manufactured by High Q, a trusted and reliable pharmaceutical company How It Works Ceftriaxone works by interfering with the synthesis of bacterial cell walls, leading to the death of the bacteria causing the infection. It is a broad-spectrum antibiotic that is effective against a wide range of bacteria, making it a versatile treatment option for many different types of infections. Directions for Use 1. This injection should be administered by a healthcare professional. 2. The dosage and frequency of administration will be determined by your doctor based on the specific infection being treated. 3. The injection is typically given intravenously over a period of time, as directed by your healthcare provider. Precautions - Inform your doctor if you have any allergies to antibiotics before using this injection. - It is important to complete the full course of treatment as prescribed by your doctor, even if you start to feel better. - Do not use this injection for viral infections such as the common cold or flu. Storage Instructions Store Dayline 250mg Iv Inj in a cool, dry place away from direct sunlight and heat. Keep it out of reach of children and pets. Do not freeze the injection. Manufacturer Information Dayline 250mg Iv Inj is manufactured by High Q, a reputable pharmaceutical company known for producing high-quality and effective medications. High Q is committed to providing safe and reliable healthcare solutions for patients worldwide.